1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nanopharmaceuticals Consumption 2016-2026

2.1.2 Nanopharmaceuticals Consumption CAGR by Region

2.2 Nanopharmaceuticals Segment by Type

2.2.1 Liposomes

2.2.2 Polymeric Micelles

2.2.3 Solid Lipid Nanoparticles

2.2.4 Microemulsion and Nnanoemulsion

2.2.5 Nanosuspension

2.3 Nanopharmaceuticals Sales by Type

2.3.1 Global Nanopharmaceuticals Sales Market Share by Type (2016-2021)

2.3.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2016-2021)

2.3.3 Global Nanopharmaceuticals Sale Price by Type (2016-2021)

2.4 Nanopharmaceuticals Segment by Application

2.4.1 Cancer and Tumor

2.4.2 Autoimmune Disorders

2.4.3 Inflammation

2.4.4 Others

2.5 Nanopharmaceuticals Sales by Application

2.5.1 Global Nanopharmaceuticals Sale Market Share by Application (2016-2021)

2.5.2 Global Nanopharmaceuticals Revenue and Market Share by Application (2016-2021)

2.5.3 Global Nanopharmaceuticals Sale Price by Application (2016-2021)

3 Global Nanopharmaceuticals by Company

3.1 Global Nanopharmaceuticals Sales Market Share by Company

3.1.1 Global Nanopharmaceuticals Sales by Company (2019-2021)

3.1.2 Global Nanopharmaceuticals Sales Market Share by Company (2019-2021)

3.2 Global Nanopharmaceuticals Revenue Market Share by Company

3.2.1 Global Nanopharmaceuticals Revenue by Company (2019-2021)

3.2.2 Global Nanopharmaceuticals Revenue Market Share by Company (2019-2021)

3.3 Global Nanopharmaceuticals Sale Price by Company

3.4 Global Manufacturers Nanopharmaceuticals Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nanopharmaceuticals Product Location Distribution

3.4.2 Players Nanopharmaceuticals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Nanopharmaceuticals by Region

4.1 Global Nanopharmaceuticals by Region

4.1.1 Global Nanopharmaceuticals Sales by Region

4.1.2 Global Nanopharmaceuticals Revenue by Region

4.2 Americas Nanopharmaceuticals Sales Growth

4.3 APAC Nanopharmaceuticals Sales Growth

4.4 Europe Nanopharmaceuticals Sales Growth

4.5 Middle East & Africa Nanopharmaceuticals Sales Growth

5 Americas

5.1 Americas Nanopharmaceuticals Sales by Country

5.1.1 Americas Nanopharmaceuticals Sales by Country (2016-2021)

5.1.2 Americas Nanopharmaceuticals Revenue by Country (2016-2021)

5.2 Americas Nanopharmaceuticals Sales by Type

5.3 Americas Nanopharmaceuticals Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nanopharmaceuticals Sales by Region

6.1.1 APAC Nanopharmaceuticals Sales by Region (2016-2021)

6.1.2 APAC Nanopharmaceuticals Revenue by Region (2016-2021)

6.2 APAC Nanopharmaceuticals Sales by Type

6.3 APAC Nanopharmaceuticals Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Nanopharmaceuticals by Country

7.1.1 Europe Nanopharmaceuticals Sales by Country (2016-2021)

7.1.2 Europe Nanopharmaceuticals Revenue by Country (2016-2021)

7.2 Europe Nanopharmaceuticals Sales by Type

7.3 Europe Nanopharmaceuticals Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nanopharmaceuticals by Country

8.1.1 Middle East & Africa Nanopharmaceuticals Sales by Country (2016-2021)

8.1.2 Middle East & Africa Nanopharmaceuticals Revenue by Country (2016-2021)

8.2 Middle East & Africa Nanopharmaceuticals Sales by Type

8.3 Middle East & Africa Nanopharmaceuticals Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Nanopharmaceuticals Distributors

10.3 Nanopharmaceuticals Customer

11 Global Nanopharmaceuticals Market Forecast

11.1 Global Nanopharmaceuticals Forecast by Region

11.1.1 Global Nanopharmaceuticals Forecast by Regions (2021-2026)

11.2.2 Global Nanopharmaceuticals Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Nanopharmaceuticals Forecast by Type

11.7 Global Nanopharmaceuticals Forecast by Application

12 Key Players Analysis

12.1 Merck

12.1.1 Merck Company Information

12.1.2 Merck Nanopharmaceuticals Product Offered

12.1.3 Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Merck Main Business Overview

12.1.5 Merck Latest Developments

12.2 Pfizer

12.2.1 Pfizer Company Information

12.2.2 Pfizer Nanopharmaceuticals Product Offered

12.2.3 Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Pfizer Main Business Overview

12.2.5 Pfizer Latest Developments

12.3 Novartis

12.3.1 Novartis Company Information

12.3.2 Novartis Nanopharmaceuticals Product Offered

12.3.3 Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Novartis Main Business Overview

12.3.5 Novartis Latest Developments

12.4 Abbott

12.4.1 Abbott Company Information

12.4.2 Abbott Nanopharmaceuticals Product Offered

12.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Abbott Main Business Overview

12.4.5 Abbott Latest Developments

12.5 GlaxoSmithKline

12.5.1 GlaxoSmithKline Company Information

12.5.2 GlaxoSmithKline Nanopharmaceuticals Product Offered

12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 GlaxoSmithKline Main Business Overview

12.5.5 GlaxoSmithKline Latest Developments

12.6 Roche

12.6.1 Roche Company Information

12.6.2 Roche Nanopharmaceuticals Product Offered

12.6.3 Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Roche Main Business Overview

12.6.5 Roche Latest Developments

12.7 Sanofi

12.7.1 Sanofi Company Information

12.7.2 Sanofi Nanopharmaceuticals Product Offered

12.7.3 Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Sanofi Main Business Overview

12.7.5 Sanofi Latest Developments

12.8 Eli Lilly

12.8.1 Eli Lilly Company Information

12.8.2 Eli Lilly Nanopharmaceuticals Product Offered

12.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Eli Lilly Main Business Overview

12.8.5 Eli Lilly Latest Developments

12.9 Astrazeneca

12.9.1 Astrazeneca Company Information

12.9.2 Astrazeneca Nanopharmaceuticals Product Offered

12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Astrazeneca Main Business Overview

12.9.5 Astrazeneca Latest Developments

12.10 Johnson & Johnson

12.10.1 Johnson & Johnson Company Information

12.10.2 Johnson & Johnson Nanopharmaceuticals Product Offered

12.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Johnson & Johnson Main Business Overview

12.10.5 Johnson & Johnson Latest Developments

12.11 Celgene

12.11.1 Celgene Company Information

12.11.2 Celgene Nanopharmaceuticals Product Offered

12.11.3 Celgene Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Celgene Main Business Overview

12.11.5 Celgene Latest Developments

12.12 Novavax

12.12.1 Novavax Company Information

12.12.2 Novavax Nanopharmaceuticals Product Offered

12.12.3 Novavax Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Novavax Main Business Overview

12.12.5 Novavax Latest Developments

12.13 Stryker

12.13.1 Stryker Company Information

12.13.2 Stryker Nanopharmaceuticals Product Offered

12.13.3 Stryker Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Stryker Main Business Overview

12.13.5 Stryker Latest Developments

12.14 Gilead Sciences

12.14.1 Gilead Sciences Company Information

12.14.2 Gilead Sciences Nanopharmaceuticals Product Offered

12.14.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Gilead Sciences Main Business Overview

12.14.5 Gilead Sciences Latest Developments

12.15 OSI Pharmaceuticals

12.15.1 OSI Pharmaceuticals Company Information

12.15.2 OSI Pharmaceuticals Nanopharmaceuticals Product Offered

12.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 OSI Pharmaceuticals Main Business Overview

12.15.5 OSI Pharmaceuticals Latest Developments

12.16 Kadmon Pharmaceuticals

12.16.1 Kadmon Pharmaceuticals Company Information

12.16.2 Kadmon Pharmaceuticals Nanopharmaceuticals Product Offered

12.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Kadmon Pharmaceuticals Main Business Overview

12.16.5 Kadmon Pharmaceuticals Latest Developments

12.17 Samyang Biopharm

12.17.1 Samyang Biopharm Company Information

12.17.2 Samyang Biopharm Nanopharmaceuticals Product Offered

12.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Samyang Biopharm Main Business Overview

12.17.5 Samyang Biopharm Latest Developments

12.18 Mitsubishi Pharma

12.18.1 Mitsubishi Pharma Company Information

12.18.2 Mitsubishi Pharma Nanopharmaceuticals Product Offered

12.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Mitsubishi Pharma Main Business Overview

12.18.5 Mitsubishi Pharma Latest Developments

12.19 Kaken Pharmaceutical

12.19.1 Kaken Pharmaceutical Company Information

12.19.2 Kaken Pharmaceutical Nanopharmaceuticals Product Offered

12.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Kaken Pharmaceutical Main Business Overview

12.19.5 Kaken Pharmaceutical Latest Developments

12.20 Selecta Biosciences

12.20.1 Selecta Biosciences Company Information

12.20.2 Selecta Biosciences Nanopharmaceuticals Product Offered

12.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 Selecta Biosciences Main Business Overview

12.20.5 Selecta Biosciences Latest Developments

12.21 Par Pharmaceutical

12.21.1 Par Pharmaceutical Company Information

12.21.2 Par Pharmaceutical Nanopharmaceuticals Product Offered

12.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.21.4 Par Pharmaceutical Main Business Overview

12.21.5 Par Pharmaceutical Latest Developments

12.22 Cerulean Pharma

12.22.1 Cerulean Pharma Company Information

12.22.2 Cerulean Pharma Nanopharmaceuticals Product Offered

12.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.22.4 Cerulean Pharma Main Business Overview

12.22.5 Cerulean Pharma Latest Developments

12.23 Navidea Biopharmaceuticals

12.23.1 Navidea Biopharmaceuticals Company Information

12.23.2 Navidea Biopharmaceuticals Nanopharmaceuticals Product Offered

12.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.23.4 Navidea Biopharmaceuticals Main Business Overview

12.23.5 Navidea Biopharmaceuticals Latest Developments

12.24 Lummy

12.24.1 Lummy Company Information

12.24.2 Lummy Nanopharmaceuticals Product Offered

12.24.3 Lummy Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.24.4 Lummy Main Business Overview

12.24.5 Lummy Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Nanopharmaceuticals Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Liposomes

Table 3. Major Players of Polymeric Micelles

Table 4. Major Players of Solid Lipid Nanoparticles

Table 5. Major Players of Microemulsion and Nnanoemulsion

Table 6. Major Players of Nanosuspension

Table 7. Global Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)

Table 8. Global Nanopharmaceuticals Sales Market Share by Type (2016-2021)

Table 9. Global Nanopharmaceuticals Revenue by Type (2016-2021) & ($ million)

Table 10. Global Nanopharmaceuticals Revenue Market Share by Type (2016-2021)

Table 11. Global Nanopharmaceuticals Sale Price by Type (2016-2021)

Table 12. Global Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)

Table 13. Global Nanopharmaceuticals Sales Market Share by Application (2016-2021)

Table 14. Global Nanopharmaceuticals Value by Application (2016-2021)

Table 15. Global Nanopharmaceuticals Revenue Market Share by Application (2016-2021)

Table 16. Global Nanopharmaceuticals Sale Price by Application (2016-2021)

Table 17. Global Nanopharmaceuticals Sales by Company (2019-2021) & (K MT)

Table 18. Global Nanopharmaceuticals Sales Market Share by Company (2019-2021)

Table 19. Global Nanopharmaceuticals Revenue by Company (2019-2021) ($ Millions)

Table 20. Global Nanopharmaceuticals Revenue Market Share by Company (2019-2021)

Table 21. Global Nanopharmaceuticals Sale Price by Company (2019-2021)

Table 22. Key Manufacturers Nanopharmaceuticals Producing Area Distribution and Sales Area

Table 23. Players Nanopharmaceuticals Products Offered

Table 24. Nanopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Nanopharmaceuticals Sales by Region (2016-2021) (K MT)

Table 28. Global Nanopharmaceuticals Sales Market Share by Region (2016-2021)

Table 29. Global Nanopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)

Table 30. Global Nanopharmaceuticals Revenue Market Share by Region (2016-2021)

Table 31. Americas Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)

Table 32. Americas Nanopharmaceuticals Sales Market Share by Country (2016-2021)

Table 33. Americas Nanopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 34. Americas Nanopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 35. Americas Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)

Table 36. Americas Nanopharmaceuticals Sales Market Share by Type (2016-2021)

Table 37. Americas Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)

Table 38. Americas Nanopharmaceuticals Sales Market Share by Application (2016-2021)

Table 39. APAC Nanopharmaceuticals Sales by Region (2016-2021) & (K MT)

Table 40. APAC Nanopharmaceuticals Sales Market Share by Region (2016-2021)

Table 41. APAC Nanopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)

Table 42. APAC Nanopharmaceuticals Revenue Market Share by Region (2016-2021)

Table 43. APAC Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)

Table 44. APAC Nanopharmaceuticals Sales Market Share by Type (2016-2021)

Table 45. APAC Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)

Table 46. APAC Nanopharmaceuticals Sales Market Share by Application (2016-2021)

Table 47. Europe Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)

Table 48. Europe Nanopharmaceuticals Sales Market Share by Country (2016-2021)

Table 49. Europe Nanopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 50. Europe Nanopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 51. Europe Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)

Table 52. Europe Nanopharmaceuticals Sales Market Share by Type (2016-2021)

Table 53. Europe Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)

Table 54. Europe Nanopharmaceuticals Sales Market Share by Application (2016-2021)

Table 55. Middle East & Africa Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)

Table 56. Middle East & Africa Nanopharmaceuticals Sales Market Share by Country (2016-2021)

Table 57. Middle East & Africa Nanopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 58. Middle East & Africa Nanopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 59. Middle East & Africa Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)

Table 60. Middle East & Africa Nanopharmaceuticals Sales Market Share by Type (2016-2021)

Table 61. Middle East & Africa Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)

Table 62. Middle East & Africa Nanopharmaceuticals Sales Market Share by Application (2016-2021)

Table 63. Key and Potential Regions of Nanopharmaceuticals

Table 64. Key Application and Potential Industries of Nanopharmaceuticals

Table 65. Key Challenges of Nanopharmaceuticals

Table 66. Key Trends of Nanopharmaceuticals

Table 67. Nanopharmaceuticals Distributors List

Table 68. Nanopharmaceuticals Customer List

Table 69. Global Nanopharmaceuticals Sales Forecast by Region (2021-2026) & (K MT)

Table 70. Global Nanopharmaceuticals Consumption Market Forecast by Region

Table 71. Global Nanopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)

Table 72. Global Nanopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)

Table 73. Americas Nanopharmaceuticals Sales Forecast by Country (2021-2026) & (K MT)

Table 74. Americas Nanopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 75. APAC Nanopharmaceuticals Sales Forecast by Region (2021-2026) & (K MT)

Table 76. APAC Nanopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)

Table 77. Europe Nanopharmaceuticals Sales Forecast by Country (2021-2026) & (K MT)

Table 78. Europe Nanopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Middle East & Africa Nanopharmaceuticals Sales Forecast by Country (2021-2026) & (K MT)

Table 80. Middle East & Africa Nanopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 81. Global Nanopharmaceuticals Sales Forecast by Type (2021-2026) & (K MT)

Table 82. Global Nanopharmaceuticals Sales Market Share Forecast by Type (2021-2026)

Table 83. Global Nanopharmaceuticals Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 84. Global Nanopharmaceuticals Revenue Market Share Forecast by Type (2021-2026)

Table 85. Global Nanopharmaceuticals Sales Forecast by Application (2021-2026) & (K MT)

Table 86. Global Nanopharmaceuticals Sales Market Share Forecast by Application (2021-2026)

Table 87. Global Nanopharmaceuticals Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 88. Global Nanopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)

Table 89. Merck Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 90. Merck Nanopharmaceuticals Product Offered

Table 91. Merck Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 92. Merck Main Business

Table 93. Merck Latest Developments

Table 94. Pfizer Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 95. Pfizer Nanopharmaceuticals Product Offered

Table 96. Pfizer Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 97. Pfizer Main Business

Table 98. Pfizer Latest Developments

Table 99. Novartis Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 100. Novartis Nanopharmaceuticals Product Offered

Table 101. Novartis Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 102. Novartis Main Business

Table 103. Novartis Latest Developments

Table 104. Abbott Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 105. Abbott Nanopharmaceuticals Product Offered

Table 106. Abbott Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 107. Abbott Main Business

Table 108. Abbott Latest Developments

Table 109. GlaxoSmithKline Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 110. GlaxoSmithKline Nanopharmaceuticals Product Offered

Table 111. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 112. GlaxoSmithKline Main Business

Table 113. GlaxoSmithKline Latest Developments

Table 114. Roche Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 115. Roche Nanopharmaceuticals Product Offered

Table 116. Roche Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 117. Roche Main Business

Table 118. Roche Latest Developments

Table 119. Sanofi Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 120. Sanofi Nanopharmaceuticals Product Offered

Table 121. Sanofi Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 122. Sanofi Main Business

Table 123. Sanofi Latest Developments

Table 124. Eli Lilly Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 125. Eli Lilly Nanopharmaceuticals Product Offered

Table 126. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 127. Eli Lilly Main Business

Table 128. Eli Lilly Latest Developments

Table 129. Astrazeneca Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 130. Astrazeneca Nanopharmaceuticals Product Offered

Table 131. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 132. Astrazeneca Main Business

Table 133. Astrazeneca Latest Developments

Table 134. Johnson & Johnson Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 135. Johnson & Johnson Nanopharmaceuticals Product Offered

Table 136. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 137. Johnson & Johnson Main Business

Table 138. Johnson & Johnson Latest Developments

Table 139. Celgene Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 140. Celgene Nanopharmaceuticals Product Offered

Table 141. Celgene Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 142. Celgene Main Business

Table 143. Celgene Latest Developments

Table 144. Novavax Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 145. Novavax Nanopharmaceuticals Product Offered

Table 146. Novavax Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 147. Novavax Main Business

Table 148. Novavax Latest Developments

Table 149. Stryker Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 150. Stryker Nanopharmaceuticals Product Offered

Table 151. Stryker Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 152. Stryker Main Business

Table 153. Stryker Latest Developments

Table 154. Gilead Sciences Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 155. Gilead Sciences Nanopharmaceuticals Product Offered

Table 156. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 157. Gilead Sciences Main Business

Table 158. Gilead Sciences Latest Developments

Table 159. OSI Pharmaceuticals Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 160. OSI Pharmaceuticals Nanopharmaceuticals Product Offered

Table 161. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 162. OSI Pharmaceuticals Main Business

Table 163. OSI Pharmaceuticals Latest Developments

Table 164. Kadmon Pharmaceuticals Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 165. Kadmon Pharmaceuticals Nanopharmaceuticals Product Offered

Table 166. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 167. Kadmon Pharmaceuticals Main Business

Table 168. Kadmon Pharmaceuticals Latest Developments

Table 169. Samyang Biopharm Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 170. Samyang Biopharm Nanopharmaceuticals Product Offered

Table 171. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 172. Samyang Biopharm Main Business

Table 173. Samyang Biopharm Latest Developments

Table 174. Mitsubishi Pharma Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 175. Mitsubishi Pharma Nanopharmaceuticals Product Offered

Table 176. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 177. Mitsubishi Pharma Main Business

Table 178. Mitsubishi Pharma Latest Developments

Table 179. Kaken Pharmaceutical Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 180. Kaken Pharmaceutical Nanopharmaceuticals Product Offered

Table 181. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 182. Kaken Pharmaceutical Main Business

Table 183. Kaken Pharmaceutical Latest Developments

Table 184. Selecta Biosciences Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 185. Selecta Biosciences Nanopharmaceuticals Product Offered

Table 186. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 187. Selecta Biosciences Main Business

Table 188. Selecta Biosciences Latest Developments

Table 189. Par Pharmaceutical Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 190. Par Pharmaceutical Nanopharmaceuticals Product Offered

Table 191. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 192. Par Pharmaceutical Main Business

Table 193. Par Pharmaceutical Latest Developments

Table 194. Cerulean Pharma Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 195. Cerulean Pharma Nanopharmaceuticals Product Offered

Table 196. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 197. Cerulean Pharma Main Business

Table 198. Cerulean Pharma Latest Developments

Table 199. Navidea Biopharmaceuticals Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 200. Navidea Biopharmaceuticals Nanopharmaceuticals Product Offered

Table 201. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 202. Navidea Biopharmaceuticals Main Business

Table 203. Navidea Biopharmaceuticals Latest Developments

Table 204. Lummy Basic Information, Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 205. Lummy Nanopharmaceuticals Product Offered

Table 206. Lummy Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)

Table 207. Lummy Main Business

Table 208. Lummy Latest Developments

List of Figures

Figure 1. Picture of Nanopharmaceuticals

Figure 2. Nanopharmaceuticals Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nanopharmaceuticals Sales Growth Rate 2016-2026 (K MT)

Figure 7. Global Nanopharmaceuticals Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Nanopharmaceuticals Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Liposomes

Figure 10. Product Picture of Polymeric Micelles

Figure 11. Product Picture of Solid Lipid Nanoparticles

Figure 12. Product Picture of Microemulsion and Nnanoemulsion

Figure 13. Product Picture of Nanosuspension

Figure 14. Global Nanopharmaceuticals Sales Market Share by Type in 2020

Figure 15. Global Nanopharmaceuticals Revenue Market Share by Type (2016-2021)

Figure 16. Nanopharmaceuticals Consumed in Cancer and Tumor

Figure 17. Global Nanopharmaceuticals Market: Cancer and Tumor (2016-2021) & (K MT)

Figure 18. Nanopharmaceuticals Consumed in Autoimmune Disorders

Figure 19. Global Nanopharmaceuticals Market: Autoimmune Disorders (2016-2021) & (K MT)

Figure 20. Nanopharmaceuticals Consumed in Inflammation

Figure 21. Global Nanopharmaceuticals Market: Inflammation (2016-2021) & (K MT)

Figure 22. Nanopharmaceuticals Consumed in Others

Figure 23. Global Nanopharmaceuticals Market: Others (2016-2021) & (K MT)

Figure 24. Global Nanopharmaceuticals Sales Market Share by Application (2016-2021)

Figure 25. Global Nanopharmaceuticals Revenue Market Share by Application in 2020

Figure 26. Nanopharmaceuticals Revenue Market by Company in 2020 ($ Million)

Figure 27. Global Nanopharmaceuticals Revenue Market Share by Company in 2020

Figure 28. Global Nanopharmaceuticals Sales Market Share by Regions (2016-2021)

Figure 29. Global Nanopharmaceuticals Revenue Market Share by Region in 2020

Figure 30. Americas Nanopharmaceuticals Sales 2016-2021 (K MT)

Figure 31. Americas Nanopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 32. APAC Nanopharmaceuticals Sales 2016-2021 (K MT)

Figure 33. APAC Nanopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 34. Europe Nanopharmaceuticals Sales 2016-2021 (K MT)

Figure 35. Europe Nanopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 36. Middle East & Africa Nanopharmaceuticals Sales 2016-2021 (K MT)

Figure 37. Middle East & Africa Nanopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 38. Americas Nanopharmaceuticals Sales Market Share by Country in 2020

Figure 39. Americas Nanopharmaceuticals Revenue Market Share by Country in 2020

Figure 40. Americas Nanopharmaceuticals Sales Market Share by Type in 2020

Figure 41. Americas Nanopharmaceuticals Sales Market Share by Application in 2020

Figure 42. United States Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 43. Canada Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 44. Mexico Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 45. Brazil Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 46. APAC Nanopharmaceuticals Sales Market Share by Region in 2020

Figure 47. APAC Nanopharmaceuticals Revenue Market Share by Regions in 2020

Figure 48. APAC Nanopharmaceuticals Sales Market Share by Type in 2020

Figure 49. APAC Nanopharmaceuticals Sales Market Share by Application in 2020

Figure 50. China Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 51. Japan Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 52. Korea Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 53. Southeast Asia Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 54. India Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 55. Australia Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 56. Europe Nanopharmaceuticals Sales Market Share by Country in 2020

Figure 57. Europe Nanopharmaceuticals Revenue Market Share by Country in 2020

Figure 58. Europe Nanopharmaceuticals Sales Market Share by Type in 2020

Figure 59. Europe Nanopharmaceuticals Sales Market Share by Application in 2020

Figure 60. Germany Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 61. France Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 62. UK Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 63. Italy Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 64. Russia Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 65. Middle East & Africa Nanopharmaceuticals Sales Market Share by Country in 2020

Figure 66. Middle East & Africa Nanopharmaceuticals Revenue Market Share by Country in 2020

Figure 67. Middle East & Africa Nanopharmaceuticals Sales Market Share by Type in 2020

Figure 68. Middle East & Africa Nanopharmaceuticals Sales Market Share by Application in 2020

Figure 69. Egypt Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 70. South Africa Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 71. Israel Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 72. Turkey Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 73. GCC Country Nanopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles